MDxHealth
MDXH
5 hedge funds and large institutions have $18.2M invested in MDxHealth in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
32% more capital invested
Capital invested by funds: $13.8M → $18.2M (+$4.36M)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.51% more ownership
Funds ownership: 1.31% → 1.82% (+0.51%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$5.68K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$21 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
Bleichroeder LP
New York
| $11.6M | – | – | – |
|
|
MP
2
MVM Partners
Boston,
Massachusetts
| $5.95M | +$6.51M | +916,666 | New |
|
|
PCM
3
Perkins Capital Management
Wayzata,
Minnesota
| $561K | -$21 | -3 | -0% |
|
|
4
UBS Group
Zurich,
Switzerland
| $17.5K | +$3.2K | +451 | +21% |
|
|
5
Barclays
London,
United Kingdom
| $5.29K | +$5.68K | +800 | New |
|
MDXH Hedge Fund Activity: Q4 2022 in Review
5 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q4 2022, worth a combined $18.2M — up 32% from $13.8M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MDXH positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $5.68K. The largest seller was Perkins Capital Management, cutting an estimated $21.
- 5 institutional investors held MDxHealth (MDXH) as of Q4 2022, up from 4 in Q3 2022.
- Funds reported $18.2M of MDxHealth stock for Q4 2022, up 32% quarter-over-quarter.
- 2 funds opened new MDxHealth positions in Q4 2022 and 1 closed out, a net change of +1 holder.
- The largest MDxHealth buyer in Q4 2022 was Barclays, an estimated $5.68K added.
- The largest MDxHealth seller in Q4 2022 was Perkins Capital Management, an estimated $21 sold.
Based on aggregated 13F filings for Q4 2022.